Freitas Marta, Pinto Joel, Ramalho Carla, Dória Sofia
Faculty of Medicine, University of Porto, Portugal.
Genetics Unit, Department of Pathology, Faculty of Medicine.
Porto Biomed J. 2018 Jul 3;3(2):e13. doi: 10.1016/j.pbj.0000000000000013. eCollection 2018 Oct.
Array comparative genomic hybridization (aCGH) has been replacing karyotype in neurodevelopment diseases or intellectual disability cases. Regarding prenatal diagnosis (PND) karyotyping is still the criterion standard technique; nevertheless, the application of aCGH in this field has been increasing dramatically and some groups recommended it as the first-tier prenatal genetic test in cases of fetal ultrasound abnormalities. Despite aCGH greater resolution, the detection of variants of unknown significance (VOUS) is not desirable, so it's need some reflexion before generalized application on PND.
The aim of this study was to analyze the prevalence and type of copy number variants (CNVs) detected in the 55 PND samples collected from pregnancies with indication to perform aCGH.
aCGH was performed using Agilent 4 × 180K microarrays and results were analyzed using CytoGenomics software.
Eight (14.5%) cases had pathogenic or likely pathogenic CNVs. VOUS were found in 21.8% of the cases, but this frequency could be minimized if only large CNVs above 1 million base pairs that are outside the clinically curated targeted regions were considered.
在神经发育疾病或智力残疾病例中,阵列比较基因组杂交(aCGH)已逐渐取代核型分析。对于产前诊断(PND),核型分析仍是标准技术;然而,aCGH在该领域的应用正在急剧增加,一些团体建议在胎儿超声异常的情况下将其作为一线产前基因检测方法。尽管aCGH具有更高的分辨率,但检测意义未明的变异(VOUS)并不理想,因此在PND中广泛应用之前需要进行一些思考。
本研究旨在分析从有指征进行aCGH的妊娠中收集的55份PND样本中检测到的拷贝数变异(CNV)的患病率和类型。
使用安捷伦4×180K微阵列进行aCGH,并使用CytoGenomics软件分析结果。
8例(14.5%)病例存在致病性或可能致病性CNV。21.8%的病例中发现了VOUS,但如果仅考虑临床筛选目标区域以外大于100万碱基对且为大CNV的情况,该频率可能会降至最低。